Article Details
Retrieved on: 2018-05-06 08:00:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Susquehanna International Group LLP acquired a new position in Summit Therapeutics during the third quarter worth $1,828,000. Finally, <b>Acadian Asset</b> <b>Management</b> LLC boosted its stake in Summit Therapeutics by 192.8% during the fourth quarter. <b>Acadian Asset Management</b> LLC now owns 144,083 ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here